New Drug Approved for Deadly Lung Condition, First in Over a Decade

(MedPage Today) — The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.
Primary support for the preferential…